Followers | 170 |
Posts | 9940 |
Boards Moderated | 3 |
Alias Born | 06/20/2022 |
Wednesday, July 06, 2022 10:35:03 AM
/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
TYPICAL SCAMMING NASDAQ 'MEDICAL' FIRM: This Company is LYING to you! Below is a QUOTE from their PR of today, which DISCLOSES the fact that their (allegedly) "groundbreaking", NON-invasive, blood-monitoring gadget is in truth VERY INVASIVE:
"The HYLA(TM) non-invasive blood sensor is attached to the outer walls of a tube that has blood flowing through it." (Quoted in relevant part; emphases added.)
https://www.prnewswire.com/news-releases/inspira-technologies-develops-a-non-invasive-blood-sensor-designed-to-alert-real-time-change-in-patients---potentially-targets-2-5-billion-abg-market-301581383.html
As you can see from their OWN (so-called) "groundbreaking" bullshit, an INVASIVE "TUBE" must first be inserted INTO the patients in question BEFORE any monitoring, testing, etc., of their BLOOD is accomplished. Do NOT be scammed by this scamming Company!!!
Recent IINN News
- Inspira™ Announces Start of Production of the INSPIRA™ ART100 • PR Newswire (US) • 05/02/2024 01:18:00 PM
- Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100 • PR Newswire (US) • 04/25/2024 12:00:00 PM
- Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures • PR Newswire (US) • 04/16/2024 12:42:00 PM
- Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections • PR Newswire (US) • 04/10/2024 12:24:00 PM
- Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb • PR Newswire (US) • 04/03/2024 12:30:00 PM
- Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager • PR Newswire (US) • 04/01/2024 12:00:00 PM
- Inspira™ Technologies Reports Full Year 2023 Financial Results • PR Newswire (US) • 03/25/2024 01:20:00 PM
- Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets • PR Newswire (US) • 03/18/2024 11:00:00 AM
- Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator • PR Newswire (US) • 03/12/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/08/2024 09:01:04 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2024 09:01:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2024 02:25:02 PM
- Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days • PR Newswire (US) • 03/04/2024 02:20:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/27/2024 12:15:04 PM
- Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone • PR Newswire (US) • 02/27/2024 12:02:00 PM
- Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements • PR Newswire (US) • 02/27/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/22/2024 02:18:17 PM
- Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies • PR Newswire (US) • 02/22/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/14/2024 02:18:42 PM
- Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System • PR Newswire (US) • 02/14/2024 12:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:05:09 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:05:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 02:15:03 PM
- Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device • PR Newswire (US) • 02/08/2024 02:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2024 01:40:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM